Original language | English (US) |
---|---|
Pages (from-to) | S1 |
Journal | American Journal of Gastroenterology |
Volume | 117 |
Issue number | 4S |
DOIs | |
State | Published - Apr 1 2022 |
Funding
Medical writing and editorial assistance was provided by Julie O'Grady, BA, and Kate Katsaval, BSc, of The Medicine Group, LLC (New Hope, PA). Funding for the advisory board meeting and medical writing support was provided by Salix Pharmaceuticals Inc., in accordance with Good Publication Practice. The authors especially thank Wm. Lesley Castro for his significant contributions at the onset of this work before his passing. Potential competing interests: D.M.B. is a consultant, advisor, and/or speaker for Salix, AbbVie (Allergan), Ironwood, Takeda, RedHill, Alnylam, AlphaSigma, Bayer, Arena Pharmaceuticals, GI Health Foundation, IFFGD, and the Rome Foundation. His research is sponsored by an unrestricted grant from the Irene D. Pritzker Foundation. ACKNOWLEDGMENT Financial support: This supplement was funded by Salix Pharmaceuticals, Inc.
ASJC Scopus subject areas
- Hepatology
- Gastroenterology